Ethel C Garnier-Amblard

Title: Inventor Ethel C. Garnier-Amblard: Pioneering NMDA Receptor Modulators

Introduction: Ethel C. Garnier-Amblard is a notable inventor based in Tucker, GA, recognized for her significant contributions to the field of pharmacology. With a focus on the modulation of NMDA receptors, her work aims to advance treatments for neurological conditions, reflecting her commitment to improving cognitive health.

Latest Patents: Ethel holds a patent for "Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto." This innovative patent discloses thieno[2,3-d]pyrimidin-4-one derivatives that function as modulators of NMDA receptors. The pharmaceutical compositions associated with this invention, including acceptable salts or prodrugs, are geared towards managing cognitive conditions, specifically targeting the prevention and treatment of neurological disorders linked to the NMDA receptor.

Career Highlights: Ethel has made remarkable strides in her career, primarily with Emory University. Her research and inventions underscore a profound understanding of the neuroscience underlying cognitive functions and the potential impact of her discoveries on therapeutic interventions.

Collaborations: Throughout her career, Ethel has collaborated with esteemed colleagues, including Stephen F. Traynelis and Lanny Steven Liebeskind. These collaborations have enriched her research endeavors and furthered the development of innovative solutions in the field.

Conclusion: Ethel C. Garnier-Amblard stands out as a pioneering inventor in the realm of NMDA receptor modulation, with her patent holding promise for the management of neurological conditions. Her work at Emory University exemplifies the fusion of research and innovation, contributing significantly to advancements in pharmacological treatments. As the medical field continues to evolve, the impact of her inventions is poised to enhance cognitive health and improve patient outcomes.